NovaBay Pharmaceuticals, Inc. Average Assets

Average Assets of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Average Assets growth rates and interactive chart.


Highlights and Quick Summary

  • Average Assets for the quarter ending September 30, 2022 was $17.3 Million (a -1.51% decrease compared to previous quarter)
  • Year-over-year quarterly Average Assets decreased by -11.73%
  • Annual Average Assets for 2021 was $36.1 Million (a 21.46% increase from previous year)
  • Annual Average Assets for 2020 was $29.7 Million (a 188.92% increase from previous year)
  • Annual Average Assets for 2019 was $10.3 Million (a 5.87% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Average Assets of NovaBay Pharmaceuticals, Inc.

Most recent Average Assetsof NBY including historical data for past 10 years.

Interactive Chart of Average Assets of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Average Assets for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $17.31 $17.57 $19.43
2021 $19.61 $14.66 $13.44 $11.77 $36.11
2020 $13.23 $15.84 $11.57 $9.6 $29.73
2019 $10.29 $12.48 $10.79 $11.77 $10.29
2018 $9.72 $10.71 $11.89 $13.25 $9.72
2017 $12.73 $13.1 $9.54 $8.81 $12.73
2016 $10.23 $10.92 $8.59 $6.54 $10.23
2015 $6.31 $8.87 $11.84 $12.67 $6.31
2014 $11.59 $11.64 $13.17 $16.3 $11.59
2013 $17.44 $12.96 $12.45 $14.73 $17.44
2012 $17.6 $15.99 $13.56 $14.35 $17.6
2011 $15.74 $15.74

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology